Cargando…
NOTCH and AKT Signalling Interact to Drive Mammary Tumour Heterogeneity
SIMPLE SUMMARY: Effective personalised cancer therapy depends on an understanding of the fundamental biological differences between tumours. Such differences may include the activation or suppression of molecular pathways involved in the development and regulation of the normal cells that give rise...
Autores principales: | Ordonez, Liliana, Tornillo, Giusy, Kendrick, Howard, Hay, Trevor, Smalley, Matthew John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486941/ https://www.ncbi.nlm.nih.gov/pubmed/37686600 http://dx.doi.org/10.3390/cancers15174324 |
Ejemplares similares
-
ERrrr…Where are the Progenitors? Hormone Receptors and Mammary Cell Heterogeneity
por: Tornillo, Giusy, et al.
Publicado: (2015) -
Rapid activation of epithelial-mesenchymal transition drives PARP inhibitor resistance in Brca2-mutant mammary tumours
por: Ordonez, Liliana D., et al.
Publicado: (2019) -
Reproductive history determines Erbb2 locus amplification, WNT signalling and tumour phenotype in a murine breast cancer model
por: Ordonez, Liliana D., et al.
Publicado: (2021) -
Dual Mechanisms of LYN Kinase Dysregulation Drive Aggressive Behavior in Breast Cancer Cells
por: Tornillo, Giusy, et al.
Publicado: (2018) -
Mouse mammary stem cells express prognostic markers for triple-negative breast cancer
por: Soady, Kelly J, et al.
Publicado: (2015)